You are here

Eli Lilly

Regeneron pens $2B pact for Hansoh's potential obesity rival to Lilly's Zepbound

Fierce Biotech

Mon, 06/2/25 - 11:17 am

GLP-1 prescriptions for weight loss soar, despite obstacles

BioPharma Dive

Wed, 05/28/25 - 10:58 am

Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics

Yahoo/Investing.com

Tue, 05/27/25 - 11:40 am

SiteOne Therapeutics

non-opioid pain treatments

Did Eli Lilly Just Say Checkmate to Novo Nordisk?

Motley Fool

Thu, 05/22/25 - 11:40 am

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs

CNBC

Thu, 05/22/25 - 10:50 am

As Eli Lilly outperforms Novo in market, it also replaces its rival in annual IDEA Innovation rankings

Fierce Pharma

Wed, 05/21/25 - 11:53 am

Lilly’s former small molecule head makes the leap to a rising biotech in obesity

Pharma Voice

Wed, 05/21/25 - 11:07 am

Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant

Fierce Pharma

Mon, 05/19/25 - 11:25 am

drug manufacturing

Eli Lilly Collaborates With Rznomics On Hearing Loss Treatment In $1.3 Billion Pact

Benzinga

Thu, 05/15/25 - 10:40 pm

RNA therapeutics

J&J, Eli Lilly join $85M financing for newly unveiled gene editing biotech Stylus

Fierce Biotech

Tue, 05/13/25 - 11:10 am

Stylus Medicine

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial

Investing.com

Sun, 05/11/25 - 10:06 pm

clinical trials

US judge sides with FDA's removal of Lilly's weight loss drug from shortage list

MSN/Reuters

Wed, 05/7/25 - 11:05 pm

Are pharma’s DTC platforms actually creating engagement with patients?

Medical Marketing and Media

Tue, 05/6/25 - 10:27 am

patient engagement

Lilly forges a $415m ALS alliance with UK biotech Alchemab

Pharmaphorum

Tue, 05/6/25 - 10:15 am

Alchemab Therapeutics

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

Motley Fool

Sun, 05/4/25 - 12:09 pm

Viking Therapeutics

WHO set to back use of weight-loss drugs for adults globally, raises cost issue

MSN/Reuters

Thu, 05/1/25 - 10:28 pm

Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance

Yahoo Finance

Thu, 05/1/25 - 11:00 am

Zealand Pharma Hires Lilly Executive as Biotech Ramps Up in Obesity

MSN/Reuters

Wed, 04/23/25 - 10:27 pm

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

CNBC

Wed, 04/23/25 - 11:01 am

compounded drugs

Eli Lilly is overtaking Novo Nordisk in the diabetes, obesity market: BMO analysts

Fierce Pharma

Thu, 04/17/25 - 11:06 pm

BMO Capital Markets

Pages